Recombinant Human ILT-3 protein (Tagged) (Biotin)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human ILT-3 protein (Tagged) (Biotin) is a Human Fragment protein, in the 17 to 257 aa range, expressed in HEK 293 cells, with >90%, suitable for SDS-PAGE.
View Alternative Names
CD85k, ILT3, LIR5, LILRB4, Leukocyte immunoglobulin-like receptor subfamily B member 4, B4, CD85 antigen-like family member K, Immunoglobulin-like transcript 3, Leukocyte immunoglobulin-like receptor 5, Monocyte inhibitory receptor HM18, ILT-3, LIR-5
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human ILT-3 protein (Tagged) (Biotin) (AB271596)
SDS-PAGE analysis of 4 μg ab271596.
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ILT-3 acts as an inhibitory receptor that modulates immune responses. It is often linked with the control of T cell activation and the maintenance of immune tolerance. ILT-3 does not form part of a larger protein complex. Its inhibitory function helps in preventing overactivation of the immune system by modulating the signaling pathways necessary for immune response. This modulation occurs through ITIM (Immunoreceptor Tyrosine-based Inhibitory Motif) domains that recruit phosphatases helping in dephosphorylating key signaling proteins and aiding in downregulation of immune cell activities.
Pathways
The ILT-3 protein is involved in important immune regulatory pathways contributing significantly to the immune checkpoint pathway. It interacts with other immunoglobulin-like receptors and is known to influence pathways involving PD-1 (Programmed cell death protein 1) and CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4). By affecting these pathways ILT-3 serves as a checkpoint that ensures immune homeostasis prevents excess inflammation and influences the balance between immune activation and suppression within the body.
Specifications
Form
Liquid
General info
Function
Inhibitory receptor involved in the down-regulation of the immune response and the development of immune tolerance (PubMed : 11875462). Receptor for FN1 (PubMed : 34089617). Receptor for apolipoprotein APOE (PubMed : 30333625). Receptor for ALCAM/CD166 (PubMed : 29263213). Inhibits receptor-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions (PubMed : 9151699). Inhibits FCGR1A/CD64-mediated monocyte activation by inducing phosphatase-mediated down-regulation of the phosphorylation of multiple proteins including LCK, SYK, LAT and ERK, leading to a reduction in TNF production (PubMed : 19833736). This inhibition of monocyte activation occurs at least in part via binding to FN1 (PubMed : 34089617). Inhibits T cell proliferation, inducing anergy, suppressing the differentiation of IFNG-producing CD8+ cytoxic T cells and enhancing the generation of CD8+ T suppressor cells (PubMed : 16493035, PubMed : 19833736, PubMed : 29263213). Induces up-regulation of CD86 on dendritic cells (PubMed : 19860908). Interferes with TNFRSF5-signaling and NF-kappa-B up-regulation (PubMed : 11875462).
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com